Designed to help promising life science startups prove their business model and develop a compelling commercialization strategy, the acclaimed FAST program draws on a high-level team of advisors to provide experience, contacts and counsel to the selected participants. Please join the California Life Sciences Institute to meet and hear opening presentations from the companies selected … Continue reading Spring 2018 Fellows All-Star Team (FAST) Opening Showcase
Please join us for a Fellows & FAST Networking Happy Hour and come mingle with our Fellows, FAST graduates, FAST advisors, and reviewers from the CLSI Network.
Join CLSA & Alexandria Real Estate Equities to mix and mingle with the best of the Bay Area’s life sciences community.
*Invitation Only – Please contact Lori@califesciences.org for more information.
Proactively understanding the implications of your regulatory pathway, identifying opportunities to engage early and productively with FDA, and developing your product with your reimbursement model in mind can directly influence your development costs, speed to market, and commercial potential. In other words, these are critical drivers for getting your innovative technology to market successfully and efficiently.
An estimated 1.6 million Americans suffer from Inflammatory Bowel Disease (IBD), an umbrella term for two distinct conditions – Crohn’s disease and ulcerative colitis – both characterized by chronic inflammation of the gastrointestinal tract. IBD can significantly affect a patient’s quality of life and may impose tremendous public health burdens, including economic costs. There is … Continue reading Enhancing Patient Access to Therapies for Inflammatory Bowel Disease (IBD)